JCRB0818 SBC-3
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB0818 | Cell Name | SBC-3 |
|---|---|---|---|
| Profile | small cell carcinoma, oat cell type | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | Age | ||
| Identity | available | Tissue for Primary Cancer | lung (cancer) |
| Case history | Metastasis | ||
| Tissue Metastasized | Genetics | small cell carcinoma (Oat cell type) | |
| Life Span | Crisis PDL | ||
| Morphology | Character | small cell carcinoma (Oat cell type) | |
| Classify | Established by | Hiraki,S. | |
| Registered by | Akiyama,M. | Regulation for Distribution | |
| Comment | Year | 1987 | |
| Medium | Eagle's minimal essential medium with 10% fetal calf serum | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week |
| Cell Number on Passage | split ratio=1/6 | Race | |
| CO2 Conc. | 5 % | Tissue Sampling | lung |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | NT | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:1330284 | In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase-nonspecific agents under the clinically equivalent area under the curve. Mitsuhashi Y,Inaba M,Sugiyama Y,Kobayashi T Cancer. 1992 Nov 15;70(10):2540-6 |
| Pubmed id:3032107 | [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance]. Kimura I,Ohnoshi T,Hiraki S,Miyamoto H Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 2):830-6 |
| Pubmed id:3012965 | Establishment and characterization of an adriamycin-resistant subline of human small cell lung cancer cells. Miyamoto H Acta Med Okayama. 1986 Apr;40(2):65-73 |
| Pubmed id:3012966 | In vitro chemosensitivity and radiosensitivity of an adriamycin-resistant subline of human small cell lung cancer cells. Miyamoto H Acta Med Okayama. 1986 Apr;40(2):75-81 |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
| Movies |
|---|
|
|
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0818 | Cell Name | |
|---|---|---|---|
| LOT No. | 09082011 | Lot Specification | distribution |
| Medium | Eagle's minimum essential medium with 10% fetal bovine serum (FBS: GIBCO Cat. # 10099) | Temperature | 37 C |
| Cell Density at Seeding | 0.6 - 3.5 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
| Doubling Time | approx. 21 hrs. | Cell Number in Vial (cells/1ml) | 6.0 x 10^6 |
| Viability at cell freezing (%) | 90.3 | Antibiotics Used | free |
| Passage Number | P49 | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - EMEM | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0818 | Cell Name | |
|---|---|---|---|
| LOT No. | 07262007 | Lot Specification | distribution |
| Medium | Eagle's minimam essential medium with 10% fetal bovine serum (FBS lot; GIBCO 484375) | Temperature | 37 C |
| Cell Density at Seeding | approx. 1.5 x 10^5 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
| Doubling Time | approx. 30 hrs | Cell Number in Vial (cells/1ml) | 2.7 x 10^6 |
| Viability at cell freezing (%) | 92.3 | Antibiotics Used | free |
| Passage Number | P49 | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST, LD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - EMEM | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0818 | Cell Name | |
|---|---|---|---|
| LOT No. | 012699 | Lot Specification | distribution |
| Medium | Eagle's minimal essential medium + 10% fetal calf serum (Biowhittaker 6M0121) | Temperature | 37℃ |
| Cell Density at Seeding | 1.0 x 10^5 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
| Doubling Time | ca 30hrs | Cell Number in Vial (cells/1ml) | 9.6 x 10^5 |
| Viability at cell freezing (%) | 96% | Antibiotics Used | free |
| Passage Number | P49 | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD(type B), LD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Exoteric Gene | ||
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0818 | Cell Name | SBC-3 |
|---|---|---|---|
| LOT No. | 033096 | Lot Specification | distribution |
| Medium | Temperature | ||
| Cell Density at Seeding | Methods for Passages | ||
| Doubling Time | Cell Number in Vial (cells/1ml) | ||
| Viability at cell freezing (%) | Antibiotics Used | ||
| Passage Number | PDL | ||
| Sterility: MYCOPLASMA | Sterility: BACTERIA | ||
| Sterility: FUNGI | Isozyme Analysis | ||
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Exoteric Gene | ||
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0818 | Cell Name | |
|---|---|---|---|
| LOT No. | 081495 | Lot Specification | distribution |
| Medium | MEM + 10% FCS | Temperature | 37 |
| Cell Density at Seeding | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week | |
| Doubling Time | Cell Number in Vial (cells/1ml) | ca3-5x10^6 | |
| Viability at cell freezing (%) | Antibiotics Used | penicillin/streptomycin | |
| Passage Number | P44 (BM3) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | confirmed aas human |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Exoteric Gene | ||
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0818 | Cell Name | SBC-3 |
|---|---|---|---|
| LOT No. | 05182021 | Lot Specification | distribution |
| Medium | Eagle's minimum essential medium (GIBCO:catalogNo.11095-080) with 10% heat inactivated fetal bovine serum (SIGMA,Cat#172012-500ML,Lot#12J396) | Temperature | 37 C |
| Cell Density at Seeding | 2.8-3.6x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA.(Split ratio=1/6) |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 5.2x10^6 |
| Viability at cell freezing (%) | 100 | Antibiotics Used | free |
| Passage Number | p49 | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:12,13 D13S317:11,12 D7S820:12,13 D16S539:9 VWA:18 TH01:6,7 AM:X,Y TPOX:8,11 CSF1PO:10,12 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 93 | Additional information |
| Images |
|---|
|
|








